Innovation in Action, July 2015

The July 2015 edition of the Pistoia Alliance newsletter, Innovation in Action, is available to download as a PDF document.

Pistoia Alliance Continues to Attract New Members

The Pistoia Alliance, a global, not-for-profit alliance of organizations that work together to lower barriers to innovation in life science R&D, has attracted a number of new members from across the industry.

Agenda announced for our US Conference 2015 in Philadelphia

We are pleased to announce the full agenda for our 2015 US Conference. If you'd like to attend, please register now! The two-day event has been planned to provide a good mix of content for the benefit of our members and friends alike, using a greater number of panel discussions to facilitate debate and discussion.

Pistoia Alliance Launches Startup Challenge

A newly launched business plan contest will ask startup companies from around the world to develop new ideas to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see small and medium enterprises compete for up to two cash prizes of US$15,000 and a period of expert mentorship from a senior industry figure drawn from the Pistoia Alliance membership.

Pistoia Alliance Overview DownloadPistoia Alliance CSCS Novartis Download


Our projects transform R&D innovation through pre-competitive collaboration.


By collaborating as equals we can overcome significant challenges too complex to tackle in isolation.


Our HELM project has won awards, and we were instrumental in setting up the tranSMART Foundation.


To deliver our vision we build upon a platform of transparency, openness, technical expertise and collaboration.

Lowering Barriers to R&D Innovation

We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.

Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles.

Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.

Interactive Ideas

With the launch of our Interactive Project Portfolio Platform (IP3) we are embracing a new level of openness, access, and transparency around our idea-to-project process. The platform is open to the public to submit new ideas, comment and vote on proposed ideas, and monitor the progress of our projects.

Sergio Rotstein, Director of Research Business Technology, Pfizer

"Through the formation of significant collaborative relationships across its member organizations, the Pistoia Alliance enables us to work jointly towards the resolution of common problems in an unprecedented fashion, resulting in a level of efficiency and interoperability that is vital to our increasingly collaborative industry.”

Michael Braxenthaler, President, Pistoia Alliance

"Pistoia-led projects have the potential to transform precompetitive R&D, making it more open and collaborative and providing a platform upon which organizations can innovate in the ways most suited to their ultimate goals."

Stephen Gallagher, Director and CEO, Dotmatics Ltd

"Dotmatics has joined the Pistoia Alliance to participate in, and help inform the debate on, key future trends in our industry. The Alliance will be an important forum for us to understand and align to our customer needs and our involvement will allow us to access and help shape new standards that will benefit all scientific software users."

Core Members

Participating Members

Contributing Members

and the following companies and individuals... Alex M. Clark, Chris Barber, Christophe Jamain, John G. Sgouros, Lab-Consultation Co., Mary Chitty, Nick Trigg, Nicola Fantini, Paul Willer, Peter Fields, Philip Quinlan, Rachel Belani Barker, Richard Hather, Richard Wife, Robert E. Schwartz, Ted Kalbfleisch, Terry Stouch, Wolfram Teetz, and Vermilion Life Sciences.


<<Jul 2015>>
29 30 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2